The study identified four different types of pain among nursing home residents.

Published Date: 02 Mar 2023

Although it is recognized that pain is common among nursing home residents, little attention has been paid to how this pain changes over time. A new study from the Regenstrief Institute and the Indiana University School of Nursing...

Read Full News

Latest News

Q3 2026 Preview: 4 FDA Decisions to Watch

Q3 2026 Preview: 4 FDA Decisions to Watch

FDA Grants Accelerated Approval to Navepegritide for Achondroplasia in Children Aged 2 Years and Older

FDA Grants Accelerated Approval to Navepegritide for Achondroplasia in Children Aged 2 Years and Older

GLP-1s Are Treating a Diagnosis. Who’s Treating the Patient?

Without nutrition and eating disorder support, clinicians prescribing GLP-1s may miss undernutrition, muscle loss, and harmful restriction.

High-Dose Probiotic Helps Patients With Chronic Diarrhea

A high-dose eight-strain probiotic is linked to a decrease in the percentage of fecal primary bile acids among patients with bile acid malabsorption.

3 Common Drugs Older Adults Might Be Overusing

Recent studies of three medications or classes of drugs widely used among older Americans illustrate the problem.

Standing Up More May Not Cut Risk for Cancer Death

Only replacing sitting with physical activity seems to help.

Todays Updates

Metabolic Agent Vutiglabridin Improves Motor Scores in Early-Stage Study of Parkinson Disease Marco Meglio

Phase 2a trial results showed 800 mg vutiglabridin significantly improved motor symptom scores compared with placebo in early-stage Parkinson's disease.

New Study Reveals Plasma Biomarkers Highlight Distinct Biological Responses to Lecanemab in Alzheimer Disease Louie Pasculli, Carlos Cruchaga, PhD

Carlos Cruchaga, PhD, director of the NeuroGenomics and Informatics Center at Washington University, discusses emerging blood-based biomarkers for monitoring biological and cognitive responses to lecanemab treatment in Alzheimer disease.

Christen Kutz, PhD, PA-C, on What Real-World Data Reveal About Treatment Transitions to Nipocalimab in Generalized Myasthenia Gravis Marco Meglio, Christen Kutz, PhD, PA-C

Christen Kutz, PhD, PA-C, discusses a retrospective survey of neurology providers examining why patients with generalized myasthenia gravis are transitioning to nipocalimab and what real-world outcomes data suggest about its role in the treatment landscape.

Brain Chat: The Overlap Years: Perimenopause, Menopause, and MS Mitzi Joi Williams, MD

Mitzi Joi Williams, MD, is joined by Jakai McEwen, DO, and Charnetta Colton-Poole, MD, to discuss the challenges of communication between patients and their health care teams, including navigating medical language, promoting shared decision-making, and advocating for clear, patient-centered care.

Advanced Therapies in Parkinson Disease: Matching the Right Treatment to the Right Patient Hubert Fernandez, MD, Louie Pasculli

An MDS 2026 plenary speaker discusses the evolving role of infusion therapies, deep brain stimulation, and focused ultrasound in Parkinson disease, including when to consider device-aided therapies and how treatment selection can be individualized.

Mistaken for a UTI: Diagnosing IgA Nephropathy, With Gaia Coppock, MD Gaia Coppock, MD

A survey of patients with IgA nephropathy shows how nonspecific symptoms and long referral waits delay diagnosis by up to two years.

Moving Corticosteroid Stewardship into Policy, With Killian Lozach, MBA Killian Lozach, MBA

Lozach outlines how the Corticosteroid Stewardship Alliance plans to bring clinician data and adverse event costs to payers and lawmakers.

Todays Updates

Metabolic Agent Vutiglabridin Improves Motor Scores in Early-Stage Study of Parkinson Disease Marco Meglio

Phase 2a trial results showed 800 mg vutiglabridin significantly improved motor symptom scores compared with placebo in early-stage Parkinson's disease.

New Study Reveals Plasma Biomarkers Highlight Distinct Biological Responses to Lecanemab in Alzheimer Disease Louie Pasculli, Carlos Cruchaga, PhD

Carlos Cruchaga, PhD, director of the NeuroGenomics and Informatics Center at Washington University, discusses emerging blood-based biomarkers for monitoring biological and cognitive responses to lecanemab treatment in Alzheimer disease.

Christen Kutz, PhD, PA-C, on What Real-World Data Reveal About Treatment Transitions to Nipocalimab in Generalized Myasthenia Gravis Marco Meglio, Christen Kutz, PhD, PA-C

Christen Kutz, PhD, PA-C, discusses a retrospective survey of neurology providers examining why patients with generalized myasthenia gravis are transitioning to nipocalimab and what real-world outcomes data suggest about its role in the treatment landscape.

Brain Chat: The Overlap Years: Perimenopause, Menopause, and MS Mitzi Joi Williams, MD

Mitzi Joi Williams, MD, is joined by Jakai McEwen, DO, and Charnetta Colton-Poole, MD, to discuss the challenges of communication between patients and their health care teams, including navigating medical language, promoting shared decision-making, and advocating for clear, patient-centered care.

Advanced Therapies in Parkinson Disease: Matching the Right Treatment to the Right Patient Hubert Fernandez, MD, Louie Pasculli

An MDS 2026 plenary speaker discusses the evolving role of infusion therapies, deep brain stimulation, and focused ultrasound in Parkinson disease, including when to consider device-aided therapies and how treatment selection can be individualized.

Mistaken for a UTI: Diagnosing IgA Nephropathy, With Gaia Coppock, MD Gaia Coppock, MD

A survey of patients with IgA nephropathy shows how nonspecific symptoms and long referral waits delay diagnosis by up to two years.

Moving Corticosteroid Stewardship into Policy, With Killian Lozach, MBA Killian Lozach, MBA

Lozach outlines how the Corticosteroid Stewardship Alliance plans to bring clinician data and adverse event costs to payers and lawmakers.

Latest News

Q3 2026 Preview: 4 FDA Decisions to Watch

FDA Grants Accelerated Approval to Navepegritide for Achondroplasia in Children Aged 2 Years and Older

Without nutrition and eating disorder support, clinicians prescribing GLP-1s may miss undernutrition, muscle loss, and harmful restriction.

A high-dose eight-strain probiotic is linked to a decrease in the percentage of fecal primary bile acids among patients with bile acid malabsorption.

Recent studies of three medications or classes of drugs widely used among older Americans illustrate the problem.

Only replacing sitting with physical activity seems to help.

News All Time

Reducing Infusion Wait Times at VA New Jersey

VA New Jersey slashed chemo infusion wait times 32% — from 164 to 106 minutes — through order templates, pre-visit bloodwork, and a fast-track room.

Evaluating the Implementation of 60-Minute Iron Infusions

Safe 60-minute iron dextran infusion protocol has been demonstrated at large institutions, but its impact on patient safety at small, rural clinics has not been reported.

Hospital Outcomes Associated With SUDs in Pancreatic Cancer

This project sought to evaluate the impact of substance use disorders on inpatient outcomes among hospitalized patients with pancreatic cancer.

Expanding CoC Standard 5.9

Smoking cessation improves treatment response and survival, while reducing recurrence and complications in cancer patients.

Cannabis Edibles Impair Driving Even Below Legal THC Limits

Cannabis edibles dose-dependently impair simulated driving performance hours after ingestion at THC blood concentrations below roadside enforcement levels.

Pollutant Exposure Tied to Increased Suicide Risk

Air pollutant exposure, especially to PM2.5, PM10, and nitrogen dioxide, is associated with increased risk for death by suicide, attempted suicide, and suicidal ideation.

Does Sex Factor in the Obstetrical Dilemma?

Baby boys tend to be larger at birth than girls. New research asks whether those differences may help explain more challenging deliveries.

SLE Linked to Increased Risk for Stroke

Patients with systemic lupus erythematosus face a substantially elevated risk for ischemic and hemorrhagic stroke compared with control individuals, a meta-analysis shows.

Shingles Vaccine Boosts Antibodies in People Living With HIV

A recombinant zoster vaccine builds strong antibody protection in people living with HIV, regardless of their CD4 count — but their cellular immune response still lags behind those without HIV.

Remote Videos Can Reliably Flag Cerebral Palsy Risk

Remote video-based assessment at 3-4 months of corrected age can reliably flag the risk for cerebral palsy in infants born very preterm.

Primary Care Quality Tied to Hospital Use in Multimorbidity

In patients with multimorbidity, better primary care checks increase the odds of outpatient and emergency care, but multimorbidity-specific checks lower the odds of elective hospital admissions.

AI in Gastroenterology: Benefits vs Harms

AI applications are poised to become the mandated standard of practice in gastroenterology, and in some institutions already are.

Esophagitis Dissecans Superficialis in Woman With Dysphagia

A woman presents with progressive dysphagia and vomiting; endoscopy reveals extensive esophageal mucosal sloughing consistent with esophagitis dissecans superficialis.

Laughter Really Is The Best Medicine

The data on laughter are more serious than you’d expect. Dr Neil Skolnik breaks down the physiological benefits of humor.

AI in Medicine Reduces Burden, Not Judgment

AI in medicine isn’t about replacing clinical reasoning. It’s about freeing up physicians to do more of what only they can do.

Gaps in Access to Maternity Care Tied to Labor Induction

Maternal residence in rural, lower-access counties is associated with an increased risk for labor induction at full term.

Recommended News For You

Children with rare gliomas have new hope thanks to clinical trial results.

Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.

Radiation therapy can promote amphiregulin, which increases growth of metastases

ASTRO Guideline Addresses Specifics of HPV-Associated Oropharyngeal Cancer

Isatuximab Boosts MRD Negativity in Multiple Myeloma

Cancer Diagnoses Still Lagging; Cancer and Family Health; New Type of Lung Cancer

Never in a million years did I think I'd have to limit my chemotherapy.

Recommended Articles For You

Exploring the Mysteries of MGUS: Uncovering the Causes and Treatments 

Clinical Guidelines for Monitoring Minimal Residual Disease Biology in Solid Tumors 

A Breakthrough in Multiple Myeloma: Darzalex Delays Disease Progression by 51% 

Metabolic Vulnerabilities in Solid Tumor Progression 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Chemotherapy Boosts Survival for Older Patients With TNBC

2.

high response rate when using a bispecific antibody to treat R/R multiple myeloma.

3.

Adult survivors of childhood cancer are at high risk for cognitive impairment, according to JAMA.

4.

Base-edited T-cell therapy offers additional hope for treating resistant leukemia.

5.

Biden's Bedtime Cancer Symptom; Top Cancer Hospitals; FDA Panel to Review MCED Test

1.

Consensus Recommendations for Healthy Hematologic Aging

2.

Exploring the Role of Fecal Leukocytes in Intestinal Health

3.

Unveiling Tumor Immunity: Pan-Cancer Proteogenomics Characterization

4.

Transfusing the Future: Exploring the Possibilities of Blood Transfusions

5.

Clinical Pharmacology of Ferroptosis-Modulating Anticancer Pharmacotherapy

1.

International Conference on Oncology, Cancer Prevention and Public Health

2.

International Conference on Cancer Nursing and Rehabilitation Strategies

3.

International Conference on Best Practices in Oncology, Cardiology and Critical Care

4.

International Conference on Innovations in Critical Care for Oncology and Cardiology

5.

International Symposium on Oncology, Cardiology and Critical Care Innovations

1.

Efficient Management of First line ALK-rearranged NSCLC - Part II

2.

Current Scenario of Cancer- Q&A Session to Close the Gap

3.

Navigating the Complexities of Ph Negative ALL - Part XII

4.

Chemotherapy: What to Expect

5.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot